SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 316 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $375,366 | -47.8% | 13,615 | -43.0% | 0.01% | -54.5% |
| Q2 2023 | $718,434 | -22.5% | 23,900 | -6.6% | 0.01% | -26.7% |
| Q1 2023 | $927,307 | +28.4% | 25,595 | +26.5% | 0.02% | +7.1% |
| Q4 2022 | $721,961 | -78.9% | 20,240 | -64.6% | 0.01% | -86.4% |
| Q2 2018 | $3,425,000 | +44.8% | 57,230 | +10.8% | 0.10% | +77.6% |
| Q1 2018 | $2,366,000 | +4.7% | 51,660 | -8.9% | 0.06% | +1.8% |
| Q4 2017 | $2,259,000 | -42.9% | 56,690 | -42.7% | 0.06% | -36.0% |
| Q3 2017 | $3,955,000 | -46.6% | 98,876 | -42.5% | 0.09% | -50.0% |
| Q2 2017 | $7,406,000 | +89.3% | 171,831 | +37.5% | 0.18% | +78.0% |
| Q1 2017 | $3,913,000 | +55.2% | 125,010 | +25.2% | 0.10% | +38.9% |
| Q4 2016 | $2,522,000 | – | 99,864 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |